| Revision as of 11:17, 20 September 2006 editLeevanjackson (talk | contribs)Extended confirmed users, Pending changes reviewers6,619 editsm seems to have been done and accepted← Previous edit | Latest revision as of 13:22, 6 August 2017 edit undo2602:304:b11e:20c0:3d77:8880:1649:22e9 (talk) ←Blanked the pageTag: talk page blanking | ||
| (37 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
| * <s>External links in the articles should be reference links.</s> | |||
| from peer review | |||
| * Both "Causes" and "Mechanism" could use some writing tweaks for clarity: | |||
| * "loss of medium spiny neurons, a GABAergic result" -- contextless without at minimum a wikilink to GABA | |||
| * "can lead to dysfunction of the proteosome system. This mitochondrial dysfunction..., the use of "this" isn't terribly clear. Does the aggregation have effects on both the proteasome and the mitochondria, or is the proteasomal deficiency the direct cause of mitochondrial dysfunction? If so, what is the mechanism? | |||
| * There's mention of the "nanotube" idea but no discussion of amyloid itself - this would be a good connection to make with other protein misfolding diseases. | |||
| * The "Genetics" section mentions that repeat number becomes unstable after 35 repeats and causes disease after 40. It should either be briefly explained why the DNA replication machinery has difficulty with repetitive sequences, or at least wikilink to DNA replication so readers can learn about it there. | |||
| * It would be interesting to expand on the age-of-onset phenomenon, which I think is a matter of interest in popular descriptions of the disease. IIRC it has been suggested that the "sharp cutoff" in number of repeats needed to create disease is an effect of human lifespan - ie 30 repeats don't cause disease because the aggregation is slow enough that the person dies before it has a neurodegenerative effect. Unfortunately I can't find the paper I'm thinking of, but is a related paper that expands on the biophysical origins of the effect. | |||
| * The "Others" section under management is very listy. | |||
| * The "Epidemiology" section could use some expansion if the data is available. Is it more prevalent in certain populations or ethnic groups? The prevalence statement also needs a citation, and there are weasel words in the ethics section. Opabinia regalis 16:47, 12 August 2006 (UTC) | |||
| * Could use another pass to reduce jargon so that non-biologists / doctors are better able to understand it. | |||
| * More references, especially peer-reviewed sources . Satyrium 01:39, 16 August 2006 (UTC) | |||
| from medical genetics | |||
| * article is a bit too 'listy' needs to have sections converted into prose | |||
| from discussion | |||
| *<s>the introduction</s> | |||
| *images/graphs of age of onset, distribution of CAG repeats,maybe the huntingtin molecule - (possibly as main image) | |||